As bioinformatics analyses suggested that EPHB2 may be a downstream target of this tsRNA, this study was developed to explore how changing tRF-1:28-Val-CAC-2 expression within NPC cells modulates their proliferative and EMT activity. The gene discussed is EPHB2; the disease is nasopharyngeal carcinoma.